ABL Texcell Diagnostics SA (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.380
-0.020 (-0.83%)
Oct 22, 2026, 3:37 PM CEST
ABL Texcell Diagnostics Market Cap
ABL Texcell Diagnostics has a market cap or net worth of €38.25 million as of October 22, 2026. It is the 31,250th most valuable company in the world and the 386th biggest in France. Its market cap has decreased by 47.72% in one year.
Market Cap
38.25M
Enterprise Value
39.20M
Revenue
11.13M
Global Rank
Country Rank
#386 France
PE Ratio
19.34
ChartMarket Cap Chart
Since November 17, 2000, ABL Texcell Diagnostics's market cap has increased from 2.51M to 38.25M, an increase of 1,424.87%. That is a compound annual growth rate of 11.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 38.25M | -20.89% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 88.15B |
| EssilorLuxottica Société anonyme | 69.17B |
| Sartorius Stedim Biotech | 20.92B |
| Eurofins Scientific SE | 13.71B |
| THX Pharma Société Anonyme | 47.70M |
| AB Science | 44.01M |
| Klea Holding | 42.67M |
| Theraclion | 38.16M |